chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia, Rash
Clinical narrative: Rash on the arm; Fever; This spontaneous case was reported by a non-health professional and describes the occurrence of RASH (Rash on the arm) and PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash on the arm) and PYREXIA (Fever). At the time of the report, RASH (Rash on the arm) and PYREXIA (Fever) outcome was unknown.            No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Blurred vision; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Jun-2021 and was forwarded to Moderna on 18-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurred vision) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VISION BLURRED (Blurred vision). At the time of the report, VISION BLURRED (Blurred vision) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication not reported Treatment information was not provided   Reporter did not allow further contact
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Cough, Gait disturbance, Hypokinesia, Influenza like illness
Clinical narrative: hypokinesia; coughing; walking difficulty; flu like symptoms; bone pain; swelling in her left arm; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (walking difficulty), PERIPHERAL SWELLING (swelling in her left arm), INFLUENZA LIKE ILLNESS (flu like symptoms), BONE PAIN (bone pain) and HYPOKINESIA (hypokinesia) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Atopic dermatitis. Concomitant products included DUPILUMAB for Atopic dermatitis.   On 21-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 23-Apr-2021, the patient experienced PERIPHERAL SWELLING (swelling in her left arm). On 21-May-2021, the patient experienced GAIT DISTURBANCE (walking difficulty), INFLUENZA LIKE ILLNESS (flu like symptoms) and BONE PAIN (bone pain). On 22-May-2021, the patient experienced HYPOKINESIA (hypokinesia) and COUGH (coughing). On 26-May-2021, HYPOKINESIA (hypokinesia) and COUGH (coughing) had resolved. At the time of the report, GAIT DISTURBANCE (walking difficulty), PERIPHERAL SWELLING (swelling in her left arm), INFLUENZA LIKE ILLNESS (flu like symptoms) and BONE PAIN (bone pain) had resolved.            Patient received injection in her arm, held dupilumab in 90 degree angle, Patient never felt the needle go in and all of a sudden there was medicine running down to her arm, felt like all the medicine leaked out instead going into her arm. Patient requested for replacement (300 mg 1 pen).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: hypokinesia; coughing; walking difficulty; flu like symptoms; bone pain; swelling in her left arm; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (walking difficulty), PERIPHERAL SWELLING (swelling in her left arm), INFLUENZA LIKE ILLNESS (flu like symptoms), BONE PAIN (bone pain) and HYPOKINESIA (hypokinesia) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Atopic dermatitis. Concomitant products included DUPILUMAB for Atopic dermatitis.   On 21-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 23-Apr-2021, the patient experienced PERIPHERAL SWELLING (swelling in her left arm). On 21-May-2021, the patient experienced GAIT DISTURBANCE (walking difficulty), INFLUENZA LIKE ILLNESS (flu like symptoms) and BONE PAIN (bone pain). On 22-May-2021, the patient experienced HYPOKINESIA (hypokinesia) and COUGH (coughing). On 26-May-2021, HYPOKINESIA (hypokinesia) and COUGH (coughing) had resolved. At the time of the report, GAIT DISTURBANCE (walking difficulty), PERIPHERAL SWELLING (swelling in her left arm), INFLUENZA LIKE ILLNESS (flu like symptoms) and BONE PAIN (bone pain) had resolved.            Patient received injection in her arm, held dupilumab in 90 degree angle, Patient never felt the needle go in and all of a sudden there was medicine running down to her arm, felt like all the medicine leaked out instead going into her arm. Patient requested for replacement (300 mg 1 pen).
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Illness, Pain
Clinical narrative: Sick; random pains all over; lightheaded; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), PAIN (random pains all over) and DIZZINESS (lightheaded) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included HYDROCHLOROTHIAZIDE for Blood pressure high, VITAMINS NOS (DAILY MULTIVITAMIN) for an unknown indication.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced ILLNESS (Sick), PAIN (random pains all over) and DIZZINESS (lightheaded). At the time of the report, ILLNESS (Sick), PAIN (random pains all over) and DIZZINESS (lightheaded) had resolved.       mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.  The patient received his first dose April 2021 sometime around the 18th to 20th of the month.   The patient's dose of hydrochlorothiazide had been changed at some point because his blood pressure numbers were getting low, stating he was usually around 132-140 for the top number.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: patient received moderna vaccine on 8Feb2021 and would like to know if she can still receive the second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (patient received moderna vaccine on 8Feb2021 and would like to know if she can still receive the second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (patient received moderna vaccine on 8Feb2021 and would like to know if she can still receive the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (patient received moderna vaccine on 8Feb2021 and would like to know if she can still receive the second dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment medications were not provided by the reporter.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine had been punctured for 26 hours; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Jun-2021 and was forwarded to Moderna on 18-Jun-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine had been punctured for 26 hours) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine had been punctured for 26 hours). On 17-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine had been punctured for 26 hours) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Myalgia, Vaccination site pain
Clinical narrative: hard to lift arm; under the left arm started hurting; pain at injection site of left arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Jun-2021 and was forwarded to Moderna on 18-Jun-2021.    This spontaneous case was reported by a patient and describes the occurrence of MOBILITY DECREASED (hard to lift arm), VACCINATION SITE PAIN (pain at injection site of left arm) and MYALGIA (under the left arm started hurting) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jun-2021, the patient experienced VACCINATION SITE PAIN (pain at injection site of left arm). On 17-Jun-2021, the patient experienced MOBILITY DECREASED (hard to lift arm) and MYALGIA (under the left arm started hurting). At the time of the report, MOBILITY DECREASED (hard to lift arm), VACCINATION SITE PAIN (pain at injection site of left arm) and MYALGIA (under the left arm started hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided Treatment medications were not provided by reporter   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: I stopped experiencing this many weeks ago; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (I stopped experiencing this many weeks ago) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (I stopped experiencing this many weeks ago). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (I stopped experiencing this many weeks ago) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Jun-2021 and was forwarded to Moderna on 18-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (I stopped experiencing this many weeks ago) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (I stopped experiencing this many weeks ago). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (I stopped experiencing this many weeks ago) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Influenza like illness, Pruritus
Clinical narrative: I have flu symptoms; my arm is red and itchy; my arm is red and itchy; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (I have flu symptoms), PRURITUS (my arm is red and itchy) and ERYTHEMA (my arm is red and itchy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (I have flu symptoms), PRURITUS (my arm is red and itchy) and ERYTHEMA (my arm is red and itchy). At the time of the report, INFLUENZA LIKE ILLNESS (I have flu symptoms), PRURITUS (my arm is red and itchy) and ERYTHEMA (my arm is red and itchy) outcome was unknown. Not Provided          Relevant concomitant medications were not reported.  Treatment medication was not provided.   Action taken with mRNA-1273 in response to the event was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Arthralgia, Illness, Pain in extremity
Clinical narrative: Sick for couple of weeks from both the doses; Right arm hurts like deep into the bone; Pain making stomach feel upset; Right arm has hurt and moving up to shoulder; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Jun-2021 and was forwarded to Moderna on 18-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick for couple of weeks from both the doses), PAIN IN EXTREMITY (Right arm hurts like deep into the bone), ABDOMINAL PAIN (Pain making stomach feel upset) and ARTHRALGIA (Right arm has hurt and moving up to shoulder) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 017B21A) for COVID-19 vaccination.     No patient history was reported by reporter.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick for couple of weeks from both the doses), PAIN IN EXTREMITY (Right arm hurts like deep into the bone), ABDOMINAL PAIN (Pain making stomach feel upset) and ARTHRALGIA (Right arm has hurt and moving up to shoulder). The patient was treated with PARACETAMOL (TYLENOL) for Illness, Abdominal pain, Arthralgia and Pain in extremity, at an unspecified dose and frequency; MENTHOL (ASPERCREME HEAT PAIN RELIEVING) for Arthralgia, Pain in extremity, Illness and Abdominal pain, at an unspecified dose and frequency and LIDOCAINE for Pain in extremity, Arthralgia, Illness and Abdominal pain, at an unspecified dose and frequency. At the time of the report, ILLNESS (Sick for couple of weeks from both the doses), PAIN IN EXTREMITY (Right arm hurts like deep into the bone), ABDOMINAL PAIN (Pain making stomach feel upset) and ARTHRALGIA (Right arm has hurt and moving up to shoulder) outcome was unknown. Not Provided          Concomitant medications were not reported.  Reportedly, the patient used heating pad which made the pain more worse.
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Jun-2021 and was forwarded to Moderna on 18-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatments were provided. Patient asked whether to take Excedrin?.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Arthralgia, Illness, Myalgia
Clinical narrative: Sick for couple of weeks from both the doses; Pain was making her stomach feel upset; right arm has hurt , Arm hurts like deep into the bone; arm has hurt and it is moving up to shoulder; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Jun-2021 and was forwarded to Moderna on 18-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick for couple of weeks from both the doses), ABDOMINAL DISCOMFORT (Pain was making her stomach feel upset), MYALGIA (right arm has hurt , Arm hurts like deep into the bone) and ARTHRALGIA (arm has hurt and it is moving up to shoulder) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 030A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick for couple of weeks from both the doses), ABDOMINAL DISCOMFORT (Pain was making her stomach feel upset), MYALGIA (right arm has hurt , Arm hurts like deep into the bone) and ARTHRALGIA (arm has hurt and it is moving up to shoulder). The patient was treated with PARACETAMOL (TYLENOL) for Illness, Abdominal pain, Arthralgia and Pain in extremity, at a dose of 1 dosage form; LIDOCAINE for Pain in extremity, Arthralgia, Abdominal pain and Illness, at a dose of 1 UNK and LIDOCAINE (ASPERCREME LIDOCAINE PATCH) for Pain in extremity and Arthralgia, at an unspecified dose and frequency. At the time of the report, ILLNESS (Sick for couple of weeks from both the doses), ABDOMINAL DISCOMFORT (Pain was making her stomach feel upset), MYALGIA (right arm has hurt , Arm hurts like deep into the bone) and ARTHRALGIA (arm has hurt and it is moving up to shoulder) outcome was unknown. Not Provided          No concomitant medication was reported. Treatment also included heating pad  which made the pain worse.   This case was linked to MOD-2021-229279 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: after you first dose to have side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (after you first dose to have side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (after you first dose to have side effects). At the time of the report, VACCINATION COMPLICATION (after you first dose to have side effects) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: extreme joint pain & It's been over 6 weeks and I still have it & joint pain is getting unbearable; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (extreme joint pain & It's been over 6 weeks and I still have it & joint pain is getting unbearable) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (extreme joint pain & It's been over 6 weeks and I still have it & joint pain is getting unbearable). At the time of the report, ARTHRALGIA (extreme joint pain & It's been over 6 weeks and I still have it & joint pain is getting unbearable) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported. No treatment medication were reported.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Fever; headache for 1 day; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and HEADACHE (headache for 1 day) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and HEADACHE (headache for 1 day). At the time of the report, PYREXIA (Fever) outcome was unknown and HEADACHE (headache for 1 day) had resolved.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-057824 (Patient Link).   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: I have missed my second moderna shot, how late is too late to get the shot; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I have missed my second moderna shot, how late is too late to get the shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I have missed my second moderna shot, how late is too late to get the shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I have missed my second moderna shot, how late is too late to get the shot) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter   Reporter did not allow further contact
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: right upper arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (right upper arm pain) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC) for Depression.    On 20-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, the patient experienced PAIN IN EXTREMITY (right upper arm pain). On 23-May-2021, PAIN IN EXTREMITY (right upper arm pain) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.   This case was linked to MOD-2021-229303 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Got my first vaccine of Moderna on the 4th of May and got the second shot on the 16th of June; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got my first vaccine of Moderna on the 4th of May and got the second shot on the 16th of June) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown and Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got my first vaccine of Moderna on the 4th of May and got the second shot on the 16th of June). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got my first vaccine of Moderna on the 4th of May and got the second shot on the 16th of June) had resolved.            No concomitant medication were reported by the reporter. Treatment medication was not reported by the reporter.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: Arm hurting around injection site; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and VACCINATION SITE PAIN (Arm hurting around injection site) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026C2ZX and 037C21A) for COVID-19 vaccination.     Concurrent medical conditions included Depression. Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC) for Depression.   On 20-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Headache). On 18-Jun-2021, the patient experienced VACCINATION SITE PAIN (Arm hurting around injection site). At the time of the report, HEADACHE (Headache) and VACCINATION SITE PAIN (Arm hurting around injection site) outcome was unknown.            No treatment drugs were reported.   This case was linked to MOD-2021-229301 (Patient Link).
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Myalgia, Nausea, Pyrexia
Clinical narrative: chest pain; fever; body aches; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain), PYREXIA (fever), MYALGIA (body aches) and NAUSEA (Nausea) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, the patient experienced CHEST PAIN (chest pain), PYREXIA (fever), MYALGIA (body aches) and NAUSEA (Nausea). At the time of the report, CHEST PAIN (chest pain), PYREXIA (fever), MYALGIA (body aches) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Jun-2021, Body temperature: 101.9 (High) High.         No concomitant medication were used. No treatment medication were used.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Musculoskeletal stiffness, Myalgia, Rash, Saliva altered
Clinical narrative: redness on arm; Covid-arm; Rash; Soreness on arm; Weird saliva reaction in her mouth; Stiffness in the shoulder/Stiffness in the neck/Stiffness in the spine; Ended up sleeping for 5 hours; This spontaneous case was reported by a consumer and describes the occurrence of SALIVA ALTERED (Weird saliva reaction in her mouth), MUSCULOSKELETAL STIFFNESS (Stiffness in the shoulder/Stiffness in the neck/Stiffness in the spine), SOMNOLENCE (Ended up sleeping for 5 hours), ERYTHEMA (redness on arm) and VACCINATION COMPLICATION (Covid-arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Ulcerative colitis (Received remicade infusions every 6 weeks) in 1990. Concurrent medical conditions included Penicillin allergy. Concomitant products included INFLIXIMAB (REMICADE), AZATHIOPRINE (IMURAN [AZATHIOPRINE]), LISINOPRIL, FISH OIL (FISH OIL OMEGA 3), PANTOPRAZOLE and BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication, ATORVASTATIN CALCIUM (LIPITOR), HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE & HCTZ) and BUPROPION HCL.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced SALIVA ALTERED (Weird saliva reaction in her mouth), MUSCULOSKELETAL STIFFNESS (Stiffness in the shoulder/Stiffness in the neck/Stiffness in the spine) and SOMNOLENCE (Ended up sleeping for 5 hours). On an unknown date, the patient experienced ERYTHEMA (redness on arm), VACCINATION COMPLICATION (Covid-arm), RASH (Rash) and MYALGIA (Soreness on arm). At the time of the report, SALIVA ALTERED (Weird saliva reaction in her mouth), MUSCULOSKELETAL STIFFNESS (Stiffness in the shoulder/Stiffness in the neck/Stiffness in the spine), SOMNOLENCE (Ended up sleeping for 5 hours), ERYTHEMA (redness on arm), VACCINATION COMPLICATION (Covid-arm), RASH (Rash) and MYALGIA (Soreness on arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   This case was linked to MOD-2021-035860 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Added new reporter details, Allery (penicillin), concomitant medications (Lipitor, Triamterene-HCTZ, Bupropion HCL) and added new events.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence, Vaccination complication
Clinical narrative: redness on arm; Covid-arm; Rash; Soreness on arm; Weird saliva reaction in her mouth; Stiffness in the shoulder/Stiffness in the neck/Stiffness in the spine; Ended up sleeping for 5 hours; This spontaneous case was reported by a consumer and describes the occurrence of SALIVA ALTERED (Weird saliva reaction in her mouth), MUSCULOSKELETAL STIFFNESS (Stiffness in the shoulder/Stiffness in the neck/Stiffness in the spine), SOMNOLENCE (Ended up sleeping for 5 hours), ERYTHEMA (redness on arm) and VACCINATION COMPLICATION (Covid-arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Ulcerative colitis (Received remicade infusions every 6 weeks) in 1990. Concurrent medical conditions included Penicillin allergy. Concomitant products included INFLIXIMAB (REMICADE), AZATHIOPRINE (IMURAN [AZATHIOPRINE]), LISINOPRIL, FISH OIL (FISH OIL OMEGA 3), PANTOPRAZOLE and BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication, ATORVASTATIN CALCIUM (LIPITOR), HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE & HCTZ) and BUPROPION HCL.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced SALIVA ALTERED (Weird saliva reaction in her mouth), MUSCULOSKELETAL STIFFNESS (Stiffness in the shoulder/Stiffness in the neck/Stiffness in the spine) and SOMNOLENCE (Ended up sleeping for 5 hours). On an unknown date, the patient experienced ERYTHEMA (redness on arm), VACCINATION COMPLICATION (Covid-arm), RASH (Rash) and MYALGIA (Soreness on arm). At the time of the report, SALIVA ALTERED (Weird saliva reaction in her mouth), MUSCULOSKELETAL STIFFNESS (Stiffness in the shoulder/Stiffness in the neck/Stiffness in the spine), SOMNOLENCE (Ended up sleeping for 5 hours), ERYTHEMA (redness on arm), VACCINATION COMPLICATION (Covid-arm), RASH (Rash) and MYALGIA (Soreness on arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   This case was linked to MOD-2021-035860 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Added new reporter details, Allery (penicillin), concomitant medications (Lipitor, Triamterene-HCTZ, Bupropion HCL) and added new events.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was provided by the reporter.  No treatment medication was provided.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Ageusia, Arthralgia, Chest pain, Decreased appetite
Clinical narrative: adverse event; fatigue; loss of appetite; loss of taste; migraines; shortness of breath; chest pain; fever; muscle pain; joint pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-Jun-2021 and was forwarded to Moderna on 21-Jun-2021.    This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-Jun-2021 and was forwarded to Moderna on 21-Jun-2021.    This spontaneous case was reported by a physician and describes the occurrence of ADVERSE EVENT (adverse event) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (adverse event).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No adverse event name is provided by the reporter.No treatment information was provided by the reporter. Primary reporter refused to be contacted.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Migraine, Myalgia, Pyrexia
Clinical narrative: adverse event; fatigue; loss of appetite; loss of taste; migraines; shortness of breath; chest pain; fever; muscle pain; joint pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-Jun-2021 and was forwarded to Moderna on 21-Jun-2021.    This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-Jun-2021 and was forwarded to Moderna on 21-Jun-2021.    This spontaneous case was reported by a physician and describes the occurrence of ADVERSE EVENT (adverse event) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (adverse event).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No adverse event name is provided by the reporter.No treatment information was provided by the reporter. Primary reporter refused to be contacted.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Gastrooesophageal reflux disease, Hiatus hernia
Clinical narrative: have had GERD that I cannot get rid of, aggravated my GERD; have a hiatal hernia and do react to mediations that way; This spontaneous case was reported by a consumer and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE (have had GERD that I cannot get rid of, aggravated my GERD) and HIATUS HERNIA (have a hiatal hernia and do react to mediations that way) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included AMLODIPINE BESYLATE and GLUCOSAMINE HYDROCHLORIDE for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (have had GERD that I cannot get rid of, aggravated my GERD) and HIATUS HERNIA (have a hiatal hernia and do react to mediations that way). At the time of the report, GASTROOESOPHAGEAL REFLUX DISEASE (have had GERD that I cannot get rid of, aggravated my GERD) had not resolved and HIATUS HERNIA (have a hiatal hernia and do react to mediations that way) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: A follow up received on 19-JUL-2021 which contained Patient's demographics,  Concomitant medications.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue
Clinical narrative: Weakness; Fatigue; This spontaneous case was reported by a physician and describes the occurrence of ASTHENIA (Weakness) and FATIGUE (Fatigue) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weakness) and FATIGUE (Fatigue). At the time of the report, ASTHENIA (Weakness) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by reporter. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-Jun-2021 and was forwarded to Moderna on 21-Jun-2021.    This spontaneous case was reported by a physician and describes the occurrence of ASTHENIA (Weakness) and FATIGUE (Fatigue) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weakness) and FATIGUE (Fatigue). At the time of the report, ASTHENIA (Weakness) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by reporter.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain). At the time of the report, PAIN IN EXTREMITY (Arm pain) had resolved.            No concomitant medication was reported. T he treatment information was unknown.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Illness, Nasopharyngitis, Tremor
Clinical narrative: Shaking; Sickness; Cold; Feeling bad; Tiredness; This spontaneous case was reported by a physician and describes the occurrence of TREMOR (Shaking), ILLNESS (Sickness), NASOPHARYNGITIS (Cold), FEELING ABNORMAL (Feeling bad) and FATIGUE (Tiredness) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    The patient's past medical history included Rheumatoid arthritis since an unknown date.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced TREMOR (Shaking), ILLNESS (Sickness), NASOPHARYNGITIS (Cold), FEELING ABNORMAL (Feeling bad) and FATIGUE (Tiredness). At the time of the report, TREMOR (Shaking), ILLNESS (Sickness), NASOPHARYNGITIS (Cold), FEELING ABNORMAL (Feeling bad) and FATIGUE (Tiredness) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided by the reporter. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-Jun-2021 and was forwarded to Moderna on 21-Jun-2021.    This spontaneous case was reported by a physician and describes the occurrence of TREMOR (Shaking), ILLNESS (Sickness), NASOPHARYNGITIS (Cold), FEELING ABNORMAL (Feeling bad) and FATIGUE (Tiredness) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    The patient's past medical history included Rheumatoid arthritis since an unknown date.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced TREMOR (Shaking), ILLNESS (Sickness), NASOPHARYNGITIS (Cold), FEELING ABNORMAL (Feeling bad) and FATIGUE (Tiredness). At the time of the report, TREMOR (Shaking), ILLNESS (Sickness), NASOPHARYNGITIS (Cold), FEELING ABNORMAL (Feeling bad) and FATIGUE (Tiredness) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No  concomitant medications were provided.  No treatment medications were reported but patient wanted to know if they could take Tynol for their headache.   Reporter did not allow further contact